News
Novo Nordisk reduces its starter dose prices through telehealth platforms to encourage weaning patients off compounded copycats.
The growing use of weight loss drugs like Ozempic raises concerns over ‘Ozempic teeth,’ linked to dry mouth and dental issues ...
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...
Dr. Mike Cirigliano joins Good Day Philadelphia to discuss the latest health topics, including the pros and cons of popular weight loss drugs.
For Sharon Osbourne, her weight loss journey hasn't exactly been smooth sailing - especially when it comes to her use of ...
Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...
Explore more
Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
Viking Therapeutics has key trial catalysts ahead and trades near biotech deal valuations, despite dilution risks. Find out ...
Speaking previously to E! News, Sharon claimed that, at her heaviest, she'd weighed over 230 pounds. She added at the time ...
Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...
Kaddis said insurers are locked in a cat-and-mouse game with drugmakers as the insurance sector invests in biosimilars and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results